Study of Difluprednate in the Treatment of Uveitis

Completed · Phase 3

Conditions studied: Uveitis

In brief

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Key facts

Study ID

NCT00501579

Run by

Sirion Therapeutics, Inc.

Last updated by the study team

2008-08-29

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of endogenous anterior uveitis in at least 1 eye

You may not qualify if…

• Presence of intermediate uveitis, posterior uveitis or panuveitis
• Corneal abrasion
• Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease
• Allergy to similar drugs, such as other corticosteroids

Where it is running

• John-Kenyon American Eye Institute — New Albany, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.